Display options
Cite
Gemeda N, Tadele A, Lemma H, et al. Development, Characterization, and Evaluation of Novel Broad-Spectrum Antimicrobial Topical Formulations from . Evid Based Complement Alternat Med. 2018;2018:9812093doi: 10.1155/2018/9812093.
Gemeda, N., Tadele, A., Lemma, H., Girma, B., Addis, G., Tesfaye, B., Abebe, A., Gemechu, W., Yirsaw, K., Teka, F., Haile, C., Amano, A., Woldkidan, S., Geleta, B., & Debella, A. (2018). Development, Characterization, and Evaluation of Novel Broad-Spectrum Antimicrobial Topical Formulations from . Evidence-based complementary and alternative medicine : eCAM, 20189812093. https://doi.org/10.1155/2018/9812093
Gemeda, Negero, et al. "Development, Characterization, and Evaluation of Novel Broad-Spectrum Antimicrobial Topical Formulations from ." Evidence-based complementary and alternative medicine : eCAM vol. 2018 (2018): 9812093. doi: https://doi.org/10.1155/2018/9812093
Gemeda N, Tadele A, Lemma H, Girma B, Addis G, Tesfaye B, Abebe A, Gemechu W, Yirsaw K, Teka F, Haile C, Amano A, Woldkidan S, Geleta B, Debella A. Development, Characterization, and Evaluation of Novel Broad-Spectrum Antimicrobial Topical Formulations from . Evid Based Complement Alternat Med. 2018 Sep 10;2018:9812093. doi: 10.1155/2018/9812093. eCollection 2018. PMID: 30275867; PMCID: PMC6151366.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2018 Sep 10;2018:9812093. doi: 10.1155/2018/9812093. eCollection 2018.

Development, Characterization, and Evaluation of Novel Broad-Spectrum Antimicrobial Topical Formulations from .

Evidence-based complementary and alternative medicine : eCAM

Negero Gemeda, Ashenif Tadele, Hirut Lemma, Biruktawit Girma, Getachew Addis, Birhanu Tesfaye, Abiy Abebe, Worku Gemechu, Kidist Yirsaw, Frehiwot Teka, Christina Haile, Aliyi Amano, Samuel Woldkidan, Bekesho Geleta, Asfaw Debella

Affiliations

  1. Traditional and Modern Medicine Research Directorate, Ethiopian Public Health Institute, P.O. Box 1242, Addis Ababa, Ethiopia.

PMID: 30275867 PMCID: PMC6151366 DOI: 10.1155/2018/9812093

Abstract

BACKGROUND: Skin infections were the most frequently encountered of all infections and the 4th leading cause of nonfatal disease burden. Topical drugs have been used for the management of skin infections. The growing concern of drug resistance to the topical agents has warned the need for continuous development of novel drug. Essential oils are the best candidate for new drug with different mode of action and target as they are rich in chemical constituents.

OBJECTIVE: To evaluate and develop safe and effective topical antimicrobial formulations from essential oil of

RESULTS: The essential oil of

CONCLUSION: In conclusion, topical formulations of

References

  1. J Ayurveda Integr Med. 2017 Oct - Dec;8(4):266-275 - PubMed
  2. Int J Food Sci. 2014;2014:874135 - PubMed
  3. Curr Opin Infect Dis. 2016 Apr;29(2):109-15 - PubMed
  4. J Pharm Anal. 2016 Apr;6(2):71-79 - PubMed
  5. J Fungi (Basel). 2017 Oct 18;3(4):null - PubMed
  6. Environ Health Insights. 2015 Nov 17;9:27-32 - PubMed
  7. Clin Infect Dis. 2014 Jul 15;59(2):147-59 - PubMed
  8. Curr Opin Pediatr. 2010 Aug;22(4):459-66 - PubMed
  9. Asian Pac J Trop Med. 2017 Aug;10(8):819-826 - PubMed
  10. Pharmaceutics. 2018 Apr 17;10(2):null - PubMed
  11. Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):271-83 - PubMed
  12. Pharm Biol. 2013 Sep;51(9):1208-18 - PubMed
  13. Antibiotics (Basel). 2017 Mar 07;6(1): - PubMed
  14. Pharmaceuticals (Basel). 2017 Nov 02;10(4):null - PubMed
  15. Pediatr Dermatol. 2012 Jul-Aug;29(4):442-7 - PubMed
  16. Future Microbiol. 2012 Aug;7(8):979-90 - PubMed
  17. Curr Opin Infect Dis. 2014 Apr;27(2):116-24 - PubMed
  18. Pharmaceuticals (Basel). 2013 Nov 25;6(12):1451-74 - PubMed
  19. J Invest Dermatol. 2014 Jun;134(6):1527-1534 - PubMed
  20. J Invest Dermatol. 2014 Jun;134(6):1499-1501 - PubMed
  21. Pharm Biol. 2015 Feb;53(2):228-34 - PubMed
  22. Medicines (Basel). 2016 Jul 28;3(3):null - PubMed
  23. Surg Gynecol Obstet. 1980 Dec;151(6):747-52 - PubMed
  24. Indian J Pharm Sci. 2009 Mar;71(2):134-6 - PubMed
  25. Medicines (Basel). 2016 Sep 22;3(4):null - PubMed

Publication Types